← Back to Search

Procedure

Lavage for Ovarian Cancer

N/A

Waitlist Available

Led By Rosana Risques

Research Sponsored by University of Washington

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up a single point in time after sample collection, no follow-up of participants is done

Awards & highlights

Study Summary

This trial is testing a new way to detect ovarian cancer in women who already have it, by looking for mutations in the tumor in samples taken from the cervix and uterus. If successful, this could be used in the future to detect ovarian cancer early in women at increased or normal risk.

Eligible Conditions

Ovarian Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ a single point in time after sample collection, no follow-up of participants is done

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~a single point in time after sample collection, no follow-up of participants is done

This trial's timeline: 3 weeks for screening, Varies for treatment, and a single point in time after sample collection, no follow-up of participants is done for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

20 Ovarian Cancer Participants With Detection of Associated TP53 Mutation in Uterine Lavage

Trial Design

1Treatment groups

Experimental Treatment

Group I: Diagnostic (pap smear, uterine lavage, tumor sample)Experimental Treatment4 Interventions

Participants undergo pap smear, uterine lavage, and collection of tumor sample during a planned surgery. DNA is then extracted from the samples and sequenced for TP53 mutations using Crispr-Duplex sequencing.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Minnesota Ovarian Cancer AllianceUNKNOWN

University of WashingtonLead Sponsor

1,737 Previous Clinical Trials

1,843,409 Total Patients Enrolled

7 Trials studying Ovarian Cancer

505 Patients Enrolled for Ovarian Cancer

Rosana RisquesPrincipal InvestigatorFred Hutch/University of Washington Cancer Consortium

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there opportunities for individuals to join this clinical exploration?

"According to clinicaltrials.gov, this medical study is currently seeking volunteers who meet the criteria outlined in the trial posting- which was first released on November 16th 2018 and last updated August 8th 2022."

Answered by AI

How many participants can this clinical trial accommodate?

"Affirmative. Clinicaltrials.gov has updated information that this clinical trial is actively enrolling new patients, having first been posted on November 16th 2018 and last updated August 8th 2022. This study requires 60 participants from a single medical centre to participate."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Lavage of the Uterine Cavity for Diagnosis of Ovarian Cancer

Barbara Norquist 2018. "Lavage of the Uterine Cavity for Diagnosis of Ovarian Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03606486.